Access cutting-edge acute kidney injury treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access acute kidney injury specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute kidney injury treatment provided free
The purpose of this Ph2b study is to characterize the dose-response relationship and to evaluate the safety and efficacy of three different single doses of TIN816 in hospitalized adult participants in an intensive care setting with a diagnosis of sepsis-associated acute kidney injury (SA-AKI).
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this acute kidney injury clinical trial in Stanford, CA
If you're searching for acute kidney injury treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute kidney injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.